Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Soulagel vs Piroxicam in Acute Extremity Pain
NCT05054023Phase 3Completed
- Sponsor
- Université de Monastir
- Start
- Oct 2021
- Primary completion
- Mar 2022
- Modality
- Hydrogel Systems, Transdermal Patches
- Countries
- 1
01
Overview
A Phase 3 trial of Soulagel in acute pain, sponsored by Université de Monastir. Started Oct 2021; status: completed.
02
Drugs
Soulagel
03
Conditions
acute pain
Beyond the preview
Go deeper on NCT05054023.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05054023.